Personal profile
Personal profile
Dr. Aparna Kamat is the director of the Division of Gynecologic Oncology for Houston Methodist and is currently the section leader for the Gynecologic Oncology service line. After completing medical training in India, Dr. Kamat completed her residency in OB/GYN at West Virginia University where she served as chief resident.
She completed her fellowship training in Gynecologic Oncology at the MD Anderson Cancer Center. During her fellowship, she received multiple awards for her research in ovarian cancer and endometrial cancer including the Virginia K. Pierce award and the Asche Murray fellowship. She also received the prestigious BIRCWH award from the N.I.H. for her research in biomarkers for ovarian cancer. Dr. Kamat currently is the principle investigator for the Gynecologic Oncology Group Clinical Trials Program at Houston Methodist and offers several state-of-the-art clinical trials for patients with gynecologic malignancies.
Her areas of expertise are robotic and minimally invasive surgical options for women with gynecologic cancers and complex pelvic disease. Her other clinical interests include hereditary risk assessment and treatment of gynecologic malignancies.
Research Area Keywords
- Cancer
Free-text keywords
- Gynecologic cancer
- Pelvic disease
- Hereditary risk assessment
- Minimally invasive surgery
- Gynecologic malignancy
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A rare case of multifocal vulvar carcinoma of mammary gland type (AMGT) with mucinous features: Differential diagnosis and literature review
Waugh, S. B., Maku, H. O., Antosh, D. D., Rozycki, S. K., Kamat, A. A., Okoye, E. I., Coffey, D. M., Deavers, M. T., Schwartz, M. R. & Ge, Y., Apr 2026, In: Gynecologic Oncology Reports. 64, p. 102068 102068.Research output: Contribution to journal › Article › peer-review
Open Access -
Programmed death-ligand 1–high squamous cell carcinoma arising in ovarian teratoma: multi-modal therapy in a rare and aggressive malignancy
Atienza, A. E., Lencina, D., Okoye, E., Kamat, A. A. & Singh, M., Feb 13 2026, (E-pub ahead of print) In: International Journal of Gynecological Cancer. p. 104600 104600.Research output: Contribution to journal › Comment/debate › peer-review
-
Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026)
Slomovitz, B. M., Weroha, S. J., Deng, W., Chon, H. S., Podder, V., Jenkins Vogel, M. T., Backes, F., Thomas, E. D., Chen, L. M., Tenney, M. E., Westin, S. N., Markham, M. J., Miller, D. S., Edelson, M. I., Muller, C. Y., Callahan, M. J., Holman, L. L., Liu, J. R., Teplinsky, E. & Kamat, A. & 13 others, , 2025, In: Journal of Clinical Oncology. 29Research output: Contribution to journal › Article › peer-review
4 Link opens in a new tab Scopus citations -
Macrophage Checkpoint Nanoimmunotherapy Has the Potential to Reduce Malignant Progression in Bioengineered In Vitro Models of Ovarian Cancer
VandenHeuvel, S. N., Chau, E., Mohapatra, A., Dabbiru, S., Roy, S., O’Connell, C., Kamat, A., Godin, B. & Raghavan, S. A., Dec 16 2024, In: ACS Applied Bio Materials. 7, 12, p. 7871-7882 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access5 Link opens in a new tab Scopus citations -
Ovarian Cancer
Hanafy, A. K., Morani, A. C., Jensen, C. T., Kamat, A., Eifel, P. J. & Bhosale, P. R., Jan 1 2022, Oncologic Imaging: A Multidisciplinary Approach. Elsevier, p. 452-475 24 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter